Seminar guide

How to Market Stem Cell Therapy Legally: What Your Ads Can't Say

How to market stem cell therapy legally, in plain English: what the FDA and FTC say, what an ad cannot claim, and links to the sources. Not legal advice.

  • By Seminar Engine
  • For medical practices
  • Published
  • 5 min read

Not legal advice. This is a plain-English summary of public FDA and FTC material, written by marketers for marketers. Rules change and your product’s status matters. Talk to your healthcare attorney before you publish any claim about a regenerative treatment.

Who polices stem cell marketing

Four groups can make your ad a problem.

  • The FDA regulates the products themselves, including stem cells and other human cell and tissue products.
  • The FTC polices advertising. Health claims must be truthful and backed by evidence.
  • State attorneys general enforce state consumer protection laws.
  • The ad platforms. Meta reviews health ads under its own policies, separate from the law.

One ad can draw all four.

What the FDA says

The FDA’s page for patients on regenerative medicine therapies is blunt. It lists products that it says are being marketed without approval, including stem cells, stromal vascular fraction, umbilical cord blood, amniotic fluid, Wharton’s jelly, orthobiologics, and exosomes. It says these products need FDA approval to be marketed to consumers, and FDA oversight in a clinical trial before approval.

Three points on that page matter for your marketing:

  • The orthopedic list. The FDA says regenerative therapies have not been approved to treat orthopedic conditions, and names osteoarthritis, tendonitis, disc disease, back pain, hip pain, knee pain, neck pain, and shoulder pain. Those are the exact topics of most regenerative seminars.
  • “FDA registered” is not approval. The FDA says that registering with the agency, or listing a study on clinicaltrials.gov, does not mean a product is legally marketed. Using either as a trust badge is the kind of suggestion it warns patients about.
  • Safety reports. The FDA lists adverse events it has received reports of, such as infections and tumor formation. Regulators read your ads with those in mind.

The rules for human cells, tissues, and cellular and tissue-based products sit in 21 CFR Part 1271. Some of those products are regulated only under that part when they meet its criteria, such as minimal manipulation and homologous use. The FDA has published guidance on how it applies those terms. Whether your product qualifies is a question for your attorney, not your marketer.

What the FTC says

The FTC’s Health Products Compliance Guidance boils its law down to two principles. Advertising must be truthful and not misleading. And before an ad runs, the advertiser must have adequate substantiation for every objective claim, stated or implied. For health benefits, that generally means competent and reliable scientific evidence.

Two words in there catch clinics: implied and every. An ad doesn’t have to say “treats” to make a treatment claim. A photo, a before-and-after, or a patient story can imply one. And the guidance applies to the whole range of promotion, not just traditional ads.

The FTC has acted on this in stem cell marketing. In October 2018 it announced a settlement with a California physician and two companies over ads claiming that “amniotic stem cell therapy” could treat serious diseases, including Parkinson’s disease, autism, multiple sclerosis, and macular degeneration. The settlement barred those claims without competent and reliable scientific evidence, imposed a $3.31 million judgment, partially suspended after a $525,000 payment, and required the defendants to notify their patients.

Claims to keep out of ads, pages, and invites

These are examples of the kind of line that gets clinics in trouble. Don’t run them. Don’t let anyone run them for you.

  • “Our stem cell therapy cures arthritis.”
  • “Regrow cartilage and avoid knee replacement.”
  • “Heal your back without surgery or drugs.”
  • “FDA-registered stem cell clinic.”
  • “95% of our patients are pain-free in 30 days.”
  • “Join the thousands we have helped walk again.” next to a patient video.

Every one of them is a health claim. Some state it. Some imply it. Several put a number on an outcome. All of them need evidence most clinics don’t have, and some describe uses the FDA says are not approved.

What you can say

Sell the event. The event is the product your ad is offering.

  • The topic. “Free talk on knee pain and your options.”
  • The logistics. Date, time, place, parking, whether a guest can come.
  • The doctor. Name, face, and credentials that are true.
  • The format. “Bring your questions. No cost to attend.”

Even with those, your attorney should see the final copy. The point is to move every claim about treatment off the ad and into the room, where your doctor can explain the evidence, the risks, and the regulatory status in context. That is what education is for.

Where Seminar Engine stands

Seminar Engine fills rooms and measures them. It does not write medical claims for a clinic.

We build the registration page, run the ads, and track the room from click to patient. Your clinic approves its medical language and owns it. Landing pages keep the claim language your clinic approves. Our own content never makes outcome claims, and it never promises registrations, attendance, or patients.

That split is deliberate. A marketer can’t know your product’s regulatory status. Your attorney can.

A pre-publish check

Run every ad, page, email, and text through five questions.

  1. Does any line state or imply what a treatment will do for the reader’s body?
  2. Is there a number about results? Source it with evidence or cut it.
  3. Does anything suggest FDA approval, registration, or endorsement?
  4. Does a testimonial, photo, or video imply an outcome?
  5. Has your healthcare attorney seen this version?

A “no” on the first four and a “yes” on the last is the only passing grade.

Sources

Sources checked October 2, 2026.

Keep reading

The marketing side of the same rooms is in regenerative medicine seminar marketing and Facebook ads for medical seminars. The full system is in the stem cell seminar guide.

The next step

Book the free 30-minute audit. Robert reviews your ads, registration page, follow-up, and tracking. He doesn’t review your medical claims. That is your attorney’s job. You leave with three to five marketing fixes. Book the audit.

Questions

Is it legal to advertise stem cell therapy?

You can advertise an educational event and your practice. Claims that an unapproved product treats a disease or condition draw FDA and FTC attention. What you can say about your specific product depends on its regulatory status, so ask your healthcare attorney.

Can I call my clinic FDA registered in ads?

The FDA says registration and listing do not mean a product is legally marketed, and that patients are misled by that suggestion. Don't use it as a trust signal without your attorney's sign-off.

Does Seminar Engine write the medical claims for our seminar?

No. Seminar Engine builds the page, runs the ads, and measures the room. Your clinic approves its medical language and owns its claims.

Free 30-minute audit

Find the leaks before you buy another room.

Free, 30 minutes, on video with Robert. He reviews your ad account, registration page, follow-up speed, and tracking from lead to patient. You leave with three to five specific fixes and what each one is likely costing you per month.

Book the free audit